# Libbs Farmacêutica

> Libbs Farmacêutica is a VC fund in São Paulo backing CRM, Health Care and Life Science. See 2 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Location: São Paulo, Brazil
- Total investments: 2
- Last investment: Jun 2019
- Lead investor: 100%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/company/libbs-farmac-utica-ltda/
- Website: https://www.libbs.com.br/
- Facebook: https://www.facebook.com/LibbsFarmaceutica/

Libbs Farmacêutica is a VC fund in São Paulo focused on CRM and Health Care. que tem o propósito de contribuir para que as pessoas alcancem uma vida plena. Há muitas formas de definir quem somos, dependendo da perspectiva de quem nos observa.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| CRM | 1 | 50% |
| Health Care | 1 | 50% |
| Life Science | 1 | 50% |
| Biotechnology | 1 | 50% |
| Information Technology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Pre-Seed | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pluricell Biotech | PluriCell wants to positively impact the lives of millions of patients suffering from chronic heart failure condition by injecting healthy bona fide lab-made human heart cells in their failing heart and improving its function and the clinical outcome of the patients. | $1M | Seed | Jun 08, 2019 |  |
| LizarBio Therapeutics | LizarBio Therapeutics is developing the first of its kind plataform to produce any cell type in the body at industrial scale (>100L). By reimagining cell culture media from the ground up, we have developed negligible-cost media to cultivate and differentiate pluripotent stem cells for therapeutic applications. Currently, we are developing twocellulat therapies focused on two key areas, namely: cardiology and neurology. | $1.1M | Pre-Seed | Dec 21, 2018 |  |

2 of 2 investments shown.

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Libbs Farmacêutica invest in?

Libbs Farmacêutica invests primarily in CRM, Health Care and Life Science startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in Brazil. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Libbs Farmacêutica last invest?

The most recent investment recorded for Libbs Farmacêutica closed in Jun 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co